Cortria Corporation's TRIA-662 Named One of 10 Most Promising ... - MarketWatch

Cortria Corporation's TRIA-662 Named One of 10 Most Promising ... MarketWatch - Oct 28, 2008 ... a new standard of care in the treatment of dyslipidemia by providing the benefits of niacin therapy without causing skin flushing," said Daniel Grau, ...

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin ... - MarketWatch

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin ... MarketWatch - Nov 9, 2008 ... of myopathy during treatment with CRESTOR may be increased with concurrent administration of some other lipid-lowering therapies (fibrates or niacin), ...

Composition Comprising Licorice Polyphenol - FLEXNEWS

Composition Comprising Licorice Polyphenol FLEXNEWS, France - Nov 20, 2008 Examples of the vitamin in the present invention include water-soluble vitamins such as vitamin B (group) (eg, vitamins B1, B2, B6, B12, folic acid, niacin, ...

Statin side effects: Weigh the benefits and risks - MayoClinic.com

Statin side effects: Weigh the benefits and risks MayoClinic.com - Oct 30, 2008 Certain other cholesterol-lowering drugs, such as gemfibrozil (Lopid) and niacin, increase the risk of liver problems even more in people who take statins. ...

Merck's 2008: The Year That Wasn't - Trading Markets (press release)

Merck's 2008: The Year That Wasn't Trading Markets (press release), CA - Nov 19, 2008 Cordaptive is a combination of Merck-developed extended-release Niacin and Laropiprant. However, the drug was approved in Europe in May. ...